Detalles de la búsqueda
1.
A Systematic Review and a Meta-analysis of Randomized Controlled Trials' Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).
Curr Oncol Rep
; 24(11): 1633-1644, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35953601
2.
Moderately hypofractionated salvage radiotherapy in patients with biochemical recurrence of prostate cancer after prostatectomy: long-term results and comparative analysis of two schedules.
Neoplasma
; 69(6): 1425-1436, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305692
3.
Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients.
Future Oncol
; 17(7): 807-815, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33508980
4.
Partial prostate re-irradiation for the treatment of isolated local recurrence of prostate cancer in patients previously treated with primary external beam radiotherapy: short-term results of a monocentric study.
Neoplasma
; 68(1): 216-226, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33030959
5.
Interleukin-2 chronotherapy for metastatic renal cell carcinoma: Results of a phase I-II study.
Cytokine
; 128: 154984, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31972343
6.
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223.
Eur J Nucl Med Mol Imaging
; 47(11): 2633-2638, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32249345
7.
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study.
World J Urol
; 37(12): 2631-2637, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30859273
8.
rs4143815-PDL1, a New Potential Immunogenetic Biomarker of Biochemical Recurrence in Locally Advanced Prostate Cancer after Radiotherapy.
Int J Mol Sci
; 20(9)2019 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31035590
9.
Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.
Tumour Biol
; 37(7): 9855-63, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26810191
10.
Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: an Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study.
BJU Int
; 117(6): 867-73, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26332130
11.
Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer.
Future Oncol
; 12(4): 493-502, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26776493
12.
Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer.
Future Oncol
; 10(6): 975-83, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24295376
13.
Navigating the evolving diagnostic and therapeutic landscape of low- and intermediate-risk prostate cancer.
Asian J Androl
; 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38738954
14.
Clinical Use of a Commercial Artificial Intelligence-Based Software for Autocontouring in Radiation Therapy: Geometric Performance and Dosimetric Impact.
Cancers (Basel)
; 15(24)2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38136281
15.
Central nervous system metastases from castration-resistant prostate cancer in the docetaxel era.
J Neurooncol
; 107(1): 191-6, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21989810
16.
Predicting Local Failure after Partial Prostate Re-Irradiation Using a Dosiomic-Based Machine Learning Model.
J Pers Med
; 12(9)2022 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36143276
17.
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group.
Clin Exp Metastasis
; 38(6): 527-537, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34748125
18.
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance.
Med Oncol
; 38(6): 72, 2021 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34008151
19.
Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without 223Ra.
Cancer Biother Radiopharm
; 36(5): 391-396, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33769088
20.
Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer.
Eur J Cancer
; 140: 140-146, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33091718